Order Article Reprints

Papasidero ID, Valli G, Marin D, Del Sasso A, De Magistris A, Cennamo E, Casalboni S, De Marco F, Rocchi R, Ndogmo Beumo B, et al. Utility of Measuring Circulating Bio-Adrenomedullin and Proenkephalin for 30-Day Mortality Risk Prediction in Patients with COVID-19 and Non-COVID-19 Interstitial Pneumonia in the Emergency Department. Medicina. 2022; 58(12):1852. https://doi.org/10.3390/medicina58121852

Papasidero, Ilaria Dafne, Gabriele Valli, Dario Marin, Alberto Del Sasso, Antonio De Magistris, Elisa Cennamo, Silvia Casalboni, Francesca De Marco, Roberta Rocchi, Brice Ndogmo Beumo, and et al. 2022. "Utility of Measuring Circulating Bio-Adrenomedullin and Proenkephalin for 30-Day Mortality Risk Prediction in Patients with COVID-19 and Non-COVID-19 Interstitial Pneumonia in the Emergency Department" Medicina 58, no. 12: 1852. https://doi.org/10.3390/medicina58121852

Papasidero, I. D., Valli, G., Marin, D., Del Sasso, A., De Magistris, A., Cennamo, E., Casalboni, S., De Marco, F., Rocchi, R., Ndogmo Beumo, B., Cusani, V., Gaudio, M., Hartmann, O., Bergman, A., Ruggieri, M. P., & Di Somma, S. (2022). Utility of Measuring Circulating Bio-Adrenomedullin and Proenkephalin for 30-Day Mortality Risk Prediction in Patients with COVID-19 and Non-COVID-19 Interstitial Pneumonia in the Emergency Department. Medicina, 58(12), 1852. https://doi.org/10.3390/medicina58121852